BioTelemetry, Inc. Deferred Tax Assets, Valuation Allowance
BioTelemetry, Inc. had Deferred Tax Assets, Valuation Allowance of $3.88 million as of 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2020-02-28
- 2019-12-31: Deferred Tax Assets, Valuation Allowance $3.88M.
- 2018-12-31: Deferred Tax Assets, Valuation Allowance $3.02M.
- 2017-12-31: Deferred Tax Assets, Valuation Allowance $6.03M.
- 2016-12-31: Deferred Tax Assets, Valuation Allowance $95.00K.
| Period end | Deferred Tax Assets, Valuation Allowance |
|---|---|
| 2019-12-31 | $3.88M 10-K · filed 2020-02-28 |
| 2018-12-31 | $3.02M 10-K · filed 2020-02-28 |
| 2017-12-31 | $6.03M 10-K · filed 2019-02-22 |
| 2016-12-31 | $95.00K 10-K · filed 2018-02-27 |
| 2015-12-31 | $49.76M 10-K · filed 2017-02-22 |
| 2014-12-31 | $53.00M 10-K · filed 2016-02-22 |
| 2013-12-31 | $50.98M 10-K · filed 2015-02-23 |
| 2013-09-30 | $678.00K 10-Q · filed 2013-11-06 |
| 2013-06-30 | $678.00K 10-Q · filed 2013-08-06 |
| 2012-12-31 | $49.15M 10-K · filed 2014-02-26 |